A case study: the patient every doctor missed.

A note on this case. The patient described here is a composite, assembled from patterns we see regularly and altered in every identifying detail. No real person is described, and nothing here is drawn from any individual's record. It is written this way deliberately: the clinical pattern is worth teaching, and no patient's privacy is worth spending to teach it.

She was forty-four and she brought a folder. Three years, four clinicians, and a stack of results in which the recurring word was normal.

The complaint was unglamorous and completely disabling. Exhaustion that sleep did not touch. Nine hours and waking as though she had not been to bed. Concentration that had thinned to the point where she read paragraphs twice. Hair coming out more than it used to. Cold when nobody else was.

She had been offered an antidepressant, twice. She had been told to reduce her stress. By the time she reached me she had largely stopped expecting an answer and was, she said, mainly there to rule things out so she could stop wondering.

What the previous panels had covered

They were not bad panels. A complete blood count, a metabolic panel, TSH, a lipid panel, fasting glucose. Everything within range. On the strength of that, every conclusion drawn had been reasonable.

What they had in common was that each was a snapshot, each was read against population ranges, and none of them had asked the questions her symptoms were pointing at.

What we added

Nothing exotic. Thyroid beyond TSH — free T4, free T3, antibodies. Ferritin, alongside the blood count she already had. Fasting insulin next to the fasting glucose that had always been fine. Vitamin D, B12, homocysteine. hsCRP. A full endocrine panel. ApoB and Lp(a), because she was forty-four and nobody had ever looked.

Three findings, none of them dramatic on their own.

Ferritin near the floor of the range, with a normal haemoglobin. Not anaemia. Depleted iron stores — a well-described cause of fatigue and hair shedding in menstruating women, and one that a complete blood count alone will not reveal. Her heavy periods, mentioned in passing and never followed up, were the mechanism.

Adequate T4, low-normal free T3, positive thyroid antibodies. Her TSH had been unremarkable throughout, which is why nobody had gone further. The antibodies indicated an autoimmune process underway; the conversion pattern was consistent with her symptoms.

Fasting insulin elevated, glucose normal. The compensation phase, running silently, as it does.

No single finding explained her. All three together explained her completely — and each one was invisible to the panel that had been run.

What we did about it

Deliberately, one thing at a time.

Iron first, because it was the most likely to produce a noticeable change and the easiest to verify — with the bleeding investigated properly rather than accepted as background. Then the metabolic piece, which meant sleep, resistance training and nutrition before anything else, because those move insulin sensitivity and because she needed to see something respond to her own effort.

The thyroid we watched. Positive antibodies with borderline conversion is not automatically a prescription, and treating it immediately would have made it impossible to know what the iron had done. We set a review point and left it.

At three months her ferritin had risen substantially and the fatigue had lifted — not resolved, lifted. At six months insulin had come down, the hair shedding had slowed, and her free T3 had improved on its own, which is common once iron is restored, because iron is required for thyroid hormone conversion. The thyroid antibodies remained. That is a long-term watch, not a fix.

What this case does not prove

I want to be careful here, because case stories are persuasive out of proportion to their evidential weight.

It does not prove that everyone with fatigue has these three findings. Many people with these symptoms have depression, sleep apnoea, chronic infection, autoimmune disease, cancer, or several things at once. A wider panel is not a shortcut past a proper clinical assessment.

It does not prove that broad testing is always right. More testing produces more incidental findings, and incidental findings produce anxiety and further tests, some of which carry their own risks. Ordering everything is not a virtue.

And it does not prove her previous clinicians were negligent. Each did what a fifteen-minute visit built around excluding disease is designed to do. The gap was structural, not personal.

What it does illustrate is narrower and, I think, sturdier: when someone is unwell and the standard panel is unremarkable, normal is not a conclusion. It is the boundary of what that particular instrument can see. Very often there is more to look at, most of it inexpensive and widely available.

The thing she said at six months was not about the labs. It was that she had stopped assuming she was imagining it. That part came before the ferritin moved — it came from someone taking the question seriously enough to ask it properly.

This article is educational and is not medical advice, diagnosis, or treatment. Laboratory results and therapies require interpretation in the context of your history, symptoms, medications, and examination, and what is appropriate differs from person to person. Nothing here should be used to start, stop, or change any treatment. Please speak with a qualified clinician who knows your case.